Dongwha Pharm.Co.,Ltd

Symbol: 000020.KS

KSC

8750

KRW

Markedspris i dag

  • 8.7584

    P/E-forhold

  • 0.0387

    PEG Ratio

  • 242.53B

    MRK Cap

  • 0.02%

    DIV Udbytte

Dongwha Pharm.Co.,Ltd (000020-KS) Årsregnskaber

På diagrammet kan du se standardtallene i dynamik for Dongwha Pharm.Co.,Ltd (000020.KS). Virksomhedens omsætning viser gennemsnittet af NaN M, som er NaN % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er NaN M, som er NaN %. Den gennemsnitlige bruttofortjeneste er NaN %. Væksten i nettoindkomst for virksomheden sidste år er NaN %, hvilket svarer til NaN % % i gennemsnit for hele virksomhedens historie.,

Balance

Når vi dykker ned i den skattemæssige udvikling for Dongwha Pharm.Co.,Ltd, ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til . Et kig tilbage på det seneste år afslører en samlet aktivændring på NaN. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til NaN i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920072006

balance-sheet.row.cash-and-short-term-investments

087234.2107694.5121509.6
120330.8
120018.9
103681.9
129681.4
66750.4
50909.4
35678.7
31184.1
34139.2
37054.4
20482.6
16779
57455.8
60390.3

balance-sheet.row.short-term-investments

014917.173347.461030
61734.4
82239.8
63067.4
98093.3
31020
6020
3055.5
3020
16020
1920
2341.6
7262.8
52778.5
50961.6

balance-sheet.row.net-receivables

074484.372638.262266.7
62773.2
81837.6
80247
68212.4
58164.1
57954.4
56486.7
55138.9
55501.9
63104.1
61067.2
51125.3
52688.3
54745.5

balance-sheet.row.inventory

070697.246783.636244
39504.2
33430.8
43717.6
36606.2
26577.3
26150.9
28382.3
30436.8
31594.4
32162.7
39026.8
37446.8
26225.3
17717

balance-sheet.row.other-current-assets

05284.4411.1178.3
135.2
169.7
240.9
0
0
0
0
0.2
0.2
0.2
0.2
0.2
0.2
0.2

balance-sheet.row.total-current-assets

0237700227527.5220198.6
222743.5
235457
227887.5
234500
151491.8
135014.7
120547.7
116759.9
121235.7
132321.4
120576.9
105351.2
136369.7
132852.9

balance-sheet.row.property-plant-equipment-net

0188330.5151152.7142850.5
130950.8
99214.8
96772.5
103746.3
142170.9
151777.3
161854.1
171902.3
183871.6
188283.8
149283.6
154301.7
71262.7
53292.6

balance-sheet.row.goodwill

020483.34555.84555.8
4555.8
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

035994.511146.713582.4
12417
5464.7
5581.2
6137
6442.3
6431.8
7107.6
8265.3
4194.7
5222.6
5292.3
4574.2
1109.4
904.5

balance-sheet.row.goodwill-and-intangible-assets

056477.815702.518138.2
16972.8
5464.7
5581.2
6137
6442.3
6431.8
7107.6
8265.3
4194.7
5222.6
5292.3
4574.2
1109.4
904.5

balance-sheet.row.long-term-investments

073880.1-16766.6-9737.1
-11957
-52000.1
-26567.7
-76135.4
-9620.9
10668.9
14883.6
11452.3
-1684.3
11036.8
10032.5
6383.5
-42829.7
-41631.3

balance-sheet.row.tax-assets

06241.864006194.2
3965.6
5652.4
3858.4
883.8
3100.3
7274.4
5624.5
4117.8
16666.9
2566.9
1265
74.1
0
52196.6

balance-sheet.row.other-non-current-assets

02342.277120.470160
71132.1
82239.8
63067.4
98093.3
31020
6020
3055.5
3667.9
0
0
37559.6
38307.1
54510.9
333.1

balance-sheet.row.total-non-current-assets

0327272.4233609227605.8
211064.3
140571.6
142711.8
132725.1
173112.7
182172.3
192525.4
199405.6
203049
207110.1
203433
203640.5
84053.3
65095.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0564972.4461136.5447804.5
433807.8
376028.6
370599.2
367225.1
324604.5
317187
313073.1
316165.5
324284.7
339431.5
324009.9
308991.7
220423
197948.4

balance-sheet.row.account-payables

031412.322231.817118.7
18522.2
17322.5
29965.4
21776.3
25671.9
17169.6
17980.1
18495.6
17645.5
22057
17923.1
16552.6
6778.5
4789.1

balance-sheet.row.short-term-debt

020371.54619.76418.5
11614.3
1793.2
0
0
0
2000
4000
4000
10000
18500
24250
31626
5825
8596.4

balance-sheet.row.tax-payables

02224.55443.87788.1
8607.2
10332.8
5101.6
16384
6055.3
3657.9
3216.6
6404.9
11585.5
3065.5
5896.5
1799.7
13505.5
7065.7

balance-sheet.row.long-term-debt-total

016127.72044.35055.7
4074.5
5116
0
0
0
0
0
2000
0
10000
18500
0
336.8
1161.8

Deferred Revenue Non Current

011756.122.940.5
16775.1
0
0
0
0
0
0
0
0
30162.2
6771.7
0
10013
7792

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

052909.447508.85988.9
5940.2
6927.8
30832.9
38940.4
29780.1
0
0
0
0
0
40484.5
44506.4
0
0

balance-sheet.row.total-non-current-liabilities

0515236900.921210
23631.6
19439.3
12400.3
9563.8
16227.2
17920.2
14432.2
15561.8
14690.1
21947.4
27437.3
7427.7
8703.3
11894.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

011756.13686.83514.6
5888.8
6909.2
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0157656.982463.287671.3
91125.6
75154
73198.6
70280.4
71679.2
87069.3
83347.3
88934.4
97290
109807.6
110094.9
100112.7
41281.1
36950.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

027931.527931.527931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5

balance-sheet.row.retained-earnings

034480.7311972.2290329
270244.8
198844.7
195595.4
239897.6
197195.9
174195.4
173103.7
170147.3
169661.3
172752.3
119334.3
113223.5
86087.7
67944

balance-sheet.row.accumulated-other-comprehensive-income-loss

0293197.7274806261485.5
246425.1
236228.7
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

016169.6-250309.3-232811.1
-213345.8
-162130.2
73564.1
29115.6
27797.9
27990.9
28690.6
29152.3
29401.9
28940.1
66649.3
67724.1
65122.8
65122.7

balance-sheet.row.total-stockholders-equity

0371779.5364400.4346934.9
331255.5
300874.6
297091
296944.7
252925.3
230117.7
229725.8
227231.1
226994.7
229623.9
213915
208879.1
179141.9
160998.2

balance-sheet.row.total-liabilities-and-stockholders-equity

0564972.4461136.5447804.5
433807.8
376028.6
370599.2
367225.1
324604.5
317187
313073.1
316165.5
324284.7
339431.5
324009.9
308991.7
220423
197948.4

balance-sheet.row.minority-interest

03553614272.813198.3
11426.7
0
309.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0407315.5378673.3360133.2
342682.2
300874.6
297400.7
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

088797.156580.951292.9
49777.4
30239.7
36499.8
21957.9
21399.1
16688.9
17939.1
14472.3
14335.7
12956.8
12374.1
13646.4
9948.8
9330.3

balance-sheet.row.total-debt

048255.4666411474.1
15688.8
6909.2
0
0
0
2000
4000
6000
10000
28500
42750
31626
6161.8
9758.1

balance-sheet.row.net-debt

0-24061.8-27683.1-49005.5
-42907.6
-30869.9
-40614.5
-31588.2
-35730.4
-42889.4
-28623.2
-22164.1
-8119.2
-6634.4
24609
22109.8
1484.4
329.5

Pengestrømsopgørelse

Det økonomiske landskab for Dongwha Pharm.Co.,Ltd har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på NaN. Virksomheden udvidede for nylig sin aktiekapital ved at udstede NaN, hvilket markerer en forskel på NaN i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på NaN i rapporteringsvalutaen. Dette er en forskydning på NaN fra året før. I samme periode har virksomheden registreret NaN, NaN og NaN, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på NaN, med en forskel fra år til år på NaN. Desuden afsatte virksomheden NaN til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet NaN, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920072006

cash-flows.row.net-income

027438.321591.219582.8
28715.1
9393.9
10068.1
47009
26254.3
5608.7
4937.2
1011.9
1311.2
17679.2
5427.2
6717.4
21495.4
8065.2

cash-flows.row.depreciation-and-amortization

01389612509.112093
10707
11484.7
11357.2
11501.1
11743.7
11864.5
12636.7
12532.2
12201
12457
18732.6
15228.1
3473.8
3320.2

cash-flows.row.deferred-income-tax

0-41674.500
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

076.100
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-19296.7-18086.3-4035.4
11363.9
-17040.7
-23576
-41682.8
-25687.1
-4417.2
-8506.8
-592.6
-2306.8
14883.4
-12149.8
5381.5
-7219.1
7894.5

cash-flows.row.account-receivables

0-4300.7-5636750.8
24046
-1972.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-12307.6-14104.5-1443.4
-5580.6
4451.4
-11789
-13584.4
-2881.9
-684
-1945.2
1157.7
568.3
4965.7
-3170.4
3925.9
-8508.4
-706.3

cash-flows.row.account-payables

02801.95014.1-1532.4
436.5
-12642.6
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-5490.3-3359.9-1810.4
-7538
-6877.1
-11787
-28098.3
-22805.2
-3733.2
-6561.6
-1750.3
-2875
9917.8
-8979.4
1455.5
1289.2
8600.8

cash-flows.row.other-non-cash-items

048727.413206.78390.8
1442.2
9447.2
-2209.4
-33347.3
13171.2
6777.2
4447.6
-4746.4
14021.3
1224.4
6577.9
2593.4
5905.3
3906

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-26345.6-20091.5-24774.2
-30114.7
-5505.8
-3701.4
-3370.3
-2503.1
-1225.9
-1684.7
-5881.6
-6844.8
-9783.2
-12571.8
-35004.1
-22170.3
-6479.9

cash-flows.row.acquisitions-net

0-18896.42599.2-2070.4
-18180.3
15195.4
243.6
-1000
-1408.9
-358.9
-408.1
-1675.9
0
-430.4
408.9
2044.8
464.5
-181.7

cash-flows.row.purchases-of-investments

0-27918.4-143537.9-105847.9
-82249.3
-101955.1
-40607.6
-85300.1
-30500
0
-3035.5
-3020
-14100
-22262.3
-2130.5
-53276.7
-117573.3
-81980.3

cash-flows.row.sales-maturities-of-investments

076140.5114969.9104048.7
100748.9
81117.8
61524.4
21041.8
2508.8
223.2
50
16039
0
22097.7
7313.8
68968.7
115209.5
69012.8

cash-flows.row.other-investing-activites

0-117.32788.33230
3964.6
-30.7
-241.6
84938.6
1474.3
381.9
-20.8
2616.8
0
948.8
-1391.5
1175.4
124.3
-545.4

cash-flows.row.net-cash-used-for-investing-activites

02863-43272-25413.9
-25830.8
-11178.4
17217.4
16310
-30429
-979.7
-5099.1
8078.4
-20944.8
-9429.4
-8371.2
-16091.8
-23945.4
-20174.5

cash-flows.row.debt-repayment

0-13500-7500-7800
-1000
0
0
0
-2000
-2000
-2000
-8000
-18500
-27029
-35000
-2336.8
-3596.4
-3596.4

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
-876.5
0
-2354.4
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-4982.2-4982.2-4969.4
-3312.9
-3312.9
-4141.2
-3043.1
-2213.2
-2234.5
-1955.2
-2234.5
-2793.1
-2793.1
-2793.1
-4189.7
-3351.7
-2793.1

cash-flows.row.other-financing-activites

024347.7469.23986.5
-1145.1
-1624.6
310
0
0
0
0
4000
0
10000
36201.3
-8753.2
2487
610.7

cash-flows.row.net-cash-used-provided-by-financing-activities

05865.5-12013-8782.9
-5458.1
-4937.6
-3831.2
-3919.6
-4213.2
-6588.9
-3955.2
-6234.5
-21293.1
-19822.2
-1591.8
-15279.6
-4461.2
-5778.8

cash-flows.row.effect-of-forex-changes-on-cash

074.9-68.248.8
-122.1
-4.3
0.2
-12.6
1
1.7
-1.2
-4.1
-4
1
0
0
0
0

cash-flows.row.net-change-in-cash

037970-26132.51883.2
20817.2
-2835.3
9026.3
-4142.2
-9159
12266.2
4459.1
10044.9
-17015.2
16993.4
8624.8
-1451.1
-4751.2
-2767.4

cash-flows.row.cash-at-end-of-period

072317.134347.160479.6
58596.4
37779.2
40614.5
31588.2
35730.4
44889.4
32623.2
28164.1
18119.2
35134.4
18141
9516.2
4677.4
9428.6

cash-flows.row.cash-at-beginning-of-period

034347.160479.658596.4
37779.2
40614.5
31588.2
35730.4
44889.4
32623.2
28164.1
18119.2
35134.4
18141
9516.2
10967.3
9428.6
12196

cash-flows.row.operating-cash-flow

029166.629220.836031.2
52228.2
13285
-4360.1
-16520
25482.2
19833.1
13514.7
8205.1
25226.8
46244
18587.8
29920.3
23655.3
23185.9

cash-flows.row.capital-expenditure

0-26345.6-20091.5-24774.2
-30114.7
-5505.8
-3701.4
-3370.3
-2503.1
-1225.9
-1684.7
-5881.6
-6844.8
-9783.2
-12571.8
-35004.1
-22170.3
-6479.9

cash-flows.row.free-cash-flow

028219129.311257
22113.5
7779.1
-8061.5
-19890.3
22979.1
18607.2
11829.9
2323.6
18382
36460.8
6016
-5083.7
1485
16706

Resultatopgørelse række

Dongwha Pharm.Co.,Ltds omsætning oplevede en ændring på NaN% sammenlignet med den foregående periode. Bruttofortjenesten for 000020.KS rapporteres til at være NaN. Virksomhedens driftsomkostninger er NaN og viser en ændring på NaN% fra sidste år. Udgifterne til afskrivninger er NaN, hvilket er en ændring på NaN% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være NaN, hvilket viser en NaN% ændring fra år til år. Salgs- og marketingomkostninger er NaN, hvilket er en ændring på NaN% sammenlignet med året før. EBITDA baseret på de seneste tal er NaN, hvilket repræsenterer en NaN% vækst i forhold til året før. Driftsindtægterne er NaN, som viser en ændring på NaN% sammenlignet med året før. Ændringen i nettoindkomsten er NaN%. Nettoindkomsten for det sidste år var NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920072006

income-statement-row.row.total-revenue

0361108.6340426.3293018.1
272075.4
307150
306602.6
258881.6
237470.8
223201.3
213472.1
220240.6
223372
234562
215279.4
145115.2
175119.8
148738.6

income-statement-row.row.cost-of-revenue

0176983.8159436.1143671.1
133409.4
185418.3
190699.4
150798
134293.4
126621.9
118268.2
124566.9
124599.3
126631.7
121482.7
79597.7
77654.1
76044.8

income-statement-row.row.gross-profit

0184124.7180990.3149347
138666
121731.7
115903.2
108083.6
103177.4
96579.4
95203.9
95673.7
98772.7
107930.3
93796.7
65517.4
97465.6
72693.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-342332.755166.453095.9
47771.6
46097.2
400.8
-1669.5
21730.5
133.8
-2801.1
-2303.2
-2310.2
-5680.1
-4513.8
-2105.4
-4623.2
-3074.3

income-statement-row.row.operating-expenses

0342332.7151075.2126848.5
115508.7
111814
104674.1
97096.3
91918.1
91766.4
87409.6
93611.5
88769.8
82308.6
83479.5
53129.2
63920.8
58522.5

income-statement-row.row.cost-and-expenses

0342332.7310511.2270519.6
248918.1
297232.3
295373.4
247894.3
226211.5
218388.3
205677.9
218178.4
213369.1
208940.3
204962.2
132726.9
141574.9
134567.4

income-statement-row.row.interest-income

03252.82387.71067.9
1839.7
1942.7
2116.7
1166.8
856.9
786.1
896.4
926.2
1376.7
669.9
989.5
1008.7
4055.6
2834.7

income-statement-row.row.interest-expense

0308370383.1
292.2
207
-3685.5
-108755.7
7.7
136.7
231.6
384.3
1056
1757.6
2446.4
1303
447.7
624.8

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

018179.7-6829.54030.9
10484.9
-487.1
3313.3
54231.4
1234.6
1187.6
-507
-354.9
-1573.3
-6588.6
-1658.8
-412.6
-673.7
-651.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-342332.755166.453095.9
47771.6
46097.2
400.8
-1669.5
21730.5
133.8
-2801.1
-2303.2
-2310.2
-5680.1
-4513.8
-2105.4
-4623.2
-3074.3

income-statement-row.row.total-operating-expenses

018179.7-6829.54030.9
10484.9
-487.1
3313.3
54231.4
1234.6
1187.6
-507
-354.9
-1573.3
-6588.6
-1658.8
-412.6
-673.7
-651.5

income-statement-row.row.interest-expense

0308370383.1
292.2
207
-3685.5
-108755.7
7.7
136.7
231.6
384.3
1056
1757.6
2446.4
1303
447.7
624.8

income-statement-row.row.depreciation-and-amortization

0138961398114940.8
12080.6
11484.7
11357.2
11501.1
11743.7
11864.5
12636.7
12532.2
12201
12457
18732.6
15228.1
3473.8
3320.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

018775.929915.122496.4
23153.4
17095
11225.8
10987.3
11259.3
4813
7794.3
2062.2
10002.9
25621.7
10317.2
12388.3
33544.8
14171.3

income-statement-row.row.income-before-tax

036955.623085.526527.3
33638.3
16607.9
14539.1
65218.7
35655.1
6000.6
5401.9
889.9
8429.6
19033.1
5430.2
11975.6
32871.2
13519.8

income-statement-row.row.income-tax-expense

08718.51494.36944.5
4923.2
7214
4470.9
18209.7
9400.8
392
464.7
-122
7118.4
1353.9
3
5258.2
11375.8
5454.6

income-statement-row.row.net-income

027438.320383.517870.4
28507.7
9402.2
10068.5
47009
26254.3
5608.7
4937.2
1011.9
1311.2
17679.2
5427.2
6717.4
21495.4
8065.2

Ofte stillede spørgsmål

Hvad er Dongwha Pharm.Co.,Ltd (000020.KS) samlede aktiver?

Dongwha Pharm.Co.,Ltd (000020.KS) samlede aktiver er 564972408621.000.

Hvad er virksomhedens årlige omsætning?

Den årlige omsætning er N/A.

Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er 0.523.

Hvad er virksomhedens frie pengestrøm?

Det frie cash flow er 101.776.

Hvad er virksomhedens nettoprofitmargin?

Nettofortjenstmargenen er 0.076.

Hvad er firmaets samlede omsætning?

Den samlede omsætning er 0.052.

Hvad er Dongwha Pharm.Co.,Ltd (000020.KS) nettoresultat (nettoindkomst)?

Nettoresultatet (nettoindkomsten) er 27438289760.000.

Hvad er virksomhedens samlede gæld?

Den samlede gæld er 48255358875.000.

Hvad er tallet for driftsudgifter?

Driftsudgifterne er 342332682000.000.

Hvad er firmaets likviditet?

Virksomhedens likviditet er 0.000.